125 related articles for article (PubMed ID: 24737372)
1. Dopamine vs nesiritide for acute heart failure with renal dysfunction--reply.
Chen HH; Redfield MM
JAMA; 2014 Apr; 311(15):1565-6. PubMed ID: 24737372
[No Abstract] [Full Text] [Related]
2. Dopamine vs nesiritide for acute heart failure with renal dysfunction.
Kumar S
JAMA; 2014 Apr; 311(15):1565. PubMed ID: 24737371
[No Abstract] [Full Text] [Related]
3. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
Chen HH; Anstrom KJ; Givertz MM; Stevenson LW; Semigran MJ; Goldsmith SR; Bart BA; Bull DA; Stehlik J; LeWinter MM; Konstam MA; Huggins GS; Rouleau JL; O'Meara E; Tang WH; Starling RC; Butler J; Deswal A; Felker GM; O'Connor CM; Bonita RE; Margulies KB; Cappola TP; Ofili EO; Mann DL; Dávila-Román VG; McNulty SE; Borlaug BA; Velazquez EJ; Lee KL; Shah MR; Hernandez AF; Braunwald E; Redfield MM;
JAMA; 2013 Dec; 310(23):2533-43. PubMed ID: 24247300
[TBL] [Abstract][Full Text] [Related]
4. Heart failure: addition of vasodilators to diuretic therapy does not improve outcome in acute heart failure.
Roberts A
Nat Rev Cardiol; 2014 Jan; 11(1):4. PubMed ID: 24302220
[No Abstract] [Full Text] [Related]
5. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
Riter HG; Redfield MM; Burnett JC; Chen HH
J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
[No Abstract] [Full Text] [Related]
6. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103
[TBL] [Abstract][Full Text] [Related]
7. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
8. Perioperative nesiritide and possible renal protection in patients with moderate to severe kidney dysfunction.
Dyke CM; Bhatia D; Aronson S; Moazami N; Mentzer RM
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1369-70. PubMed ID: 19026832
[No Abstract] [Full Text] [Related]
9. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Saltzberg MT
Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
[TBL] [Abstract][Full Text] [Related]
11. Nesiritide speeds recovery time for heart failure patients.
Morrow T
Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161
[No Abstract] [Full Text] [Related]
12. Is there still a role for low-dose dopamine use in acute heart failure?
Torres-Courchoud I; Chen HH
Curr Opin Crit Care; 2014 Oct; 20(5):467-71. PubMed ID: 25137402
[TBL] [Abstract][Full Text] [Related]
13. ROSE-AHF and lessons learned.
Jain AK; Chen HH
Curr Heart Fail Rep; 2014 Sep; 11(3):260-5. PubMed ID: 24966060
[TBL] [Abstract][Full Text] [Related]
14. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
Munger MA; Ng TM; Van Tassell BW
Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
[TBL] [Abstract][Full Text] [Related]
15. Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial.
Yancy CW
Heart Fail Rev; 2004 Jul; 9(3):209-16. PubMed ID: 15809819
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
[TBL] [Abstract][Full Text] [Related]
17. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).
Yancy CW; Singh A
Am J Cardiol; 2006 Jul; 98(2):226-9. PubMed ID: 16828598
[TBL] [Abstract][Full Text] [Related]
18. Impact of preoperative nesiritide on renal function after mitral valve surgery.
Salzberg SP; Emmert MY; Vassalotti J; Nandiwada DR; Adams DH
Heart Surg Forum; 2009 Aug; 12(4):E217-8. PubMed ID: 19683992
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of intravenous nesiritide on cardiac contractility in heart failure.
Shah SJ; Michaels AD
J Card Fail; 2010 Sep; 16(9):720-7. PubMed ID: 20797595
[TBL] [Abstract][Full Text] [Related]
20. Nesiritide: the wrong controversy.
Somberg JC
Am J Ther; 2005; 12(5):377-8. PubMed ID: 16148421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
